🇺🇸

US SEC Filing Intelligence

· daily

VA Healthcare & Services Contracts — May 07, 2026

The VA Healthcare & Services stream saw $159,996,058 in total obligations across two contracts, entirely civilian with 0/2 defense-related and average signal strength of 4.0/10. Dominant agency is Department of Veterans Affairs, focusing on medical disability examinations ($106M to Veterans Evaluation Services, Inc.) and health IT encoder software/support ($54M to Solventum Health Information Systems, Inc., 3M subsidiary). Both are neutral signals from full and open competition firm-fixed price awards, with VES showing substantial $94.3M outlay execution on its completed 2021 contract and Solventum at $23.9M outlay on its ongoing award to potential 2026 end. Highest-conviction signal is VES's high execution rate indicating revenue reliability for veteran-owned providers. Key risk: high pricing risk on firm-fixed structures and post-2021 re-compete vulnerability for VES.

2 total filings
· daily

New Federal Contractors — May 07, 2026

This digest synthesizes 18 new federal contracts totaling $1,337,470,948 in obligations from May 07, 2026, overwhelmingly civilian (17/18) with only ABSS SOLUTIONS INC's $113M biomedical R&D at Lackland AFB defense-related via GSA. Dominant themes include IT modernization and engineering services for HHS/CMS (VENTERA LLC $84M, Flexion Inc $49M), DHS/ICE (Palantir Technologies Inc $86M, THE GEO GROUP $51M), and DOE (BWXT Nuclear Operations Group $80M HALEU processing). Highest-conviction bullish signal is BWXT's $80M non-competed DOE award with $56M outlayed, signaling nuclear moat durability. Key risk is high fixed-price execution exposure across $1B+ obligations (e.g., VETERANS EVALUATION SERVICES $106M fully committed but past-dated) and $0 outlays on future contracts like Palantir and Olsson Industrial Electric ($69M). Watch multi-year option exercises amid civilian agency budget cycles.

18 total filings
· daily

Significant Contract Modifications ($10M+) — May 07, 2026

These 18 significant contract modifications totaling $1,337,470,948 in obligations are overwhelmingly civilian (17/18 contracts, ~99.9% value), with only ABSS Solutions' $113M GSA award at Lackland AFB qualifying as defense-related. Dominant themes include IT/services for HHS/CMS (VENTERA $84M, Flexion $49M), DHS/ICE (Palantir $86M, GEO Group $51M), and DOE (BWXT $80M HALEU processing), alongside engineering/health R&D across VA, NOAA, and NASA. Highest-conviction bullish signal is BWXT Nuclear Operations Group's $79.8M DOE NNSA non-competed HALEU processing award (strength 7/10, materiality 8/10), signaling durable nuclear revenue through 2028. Key risk is pervasive high fixed-price execution risk across 12+ contracts (e.g., VES $106M VA fully committed but past-dated), compounded by $0 outlays on future-dated awards like Palantir and Olsson ($68.7M Interior). Watch multi-year option exercises, especially VENTERA's $18M upside to $102M CMS ceiling.

18 total filings
· daily

Contract Deobligations Alert — May 07, 2026

This Contract Deobligations Alert captures $1,337,470,948 in total obligations across 18 contracts on May 07, 2026, with only 1 defense-related (ABSS Solutions at Lackland AFB via GSA) and 17 civilian-focused awards spanning agencies like GSA, VA, DHS, DOE, and HHS. Dominant themes include civilian IT modernization and health/services support, with bullish signals concentrated in multi-year delivery orders for Palantir ($86M DHS ICE SaaS), BWXT ($80M DOE HALEU processing), and Lynker ($99M Commerce NOAA). Highest-conviction bullish signal is BWXT Nuclear Operations Group's $79.8M non-competed DOE award for specialized HALEU processing through 2028, signaling durable nuclear revenue amid DOE priorities. Key risk is high fixed-price execution exposure across 12 contracts (e.g., VES $106M VA, Olsson $69M Interior), compounded by $0 outlays on four future-dated awards totaling $277M (Palantir, GDIT, Olsson, GEO). Watch multi-year option exercises and outlay ramps on top materiality contracts.

18 total filings
· daily

Contract Option Exercises — May 07, 2026

This digest synthesizes 18 contract option exercises totaling $1,337,470,948 in obligations, with only 1/18 defense-related (Booz Allen Hamilton's $112.7M GSA award for Army SETA services) and the rest civilian-led by agencies including GSA, VA, DHS, HHS, and DOE. Dominant themes center on civilian IT modernization, health services, and environmental/nuclear support, with no clear defense acceleration. Highest-conviction bullish signal is BWXT Nuclear Operations Group's $79.8M DOE NNSA award for HALEU processing (strength 7/10, materiality 8/10), signaling durable nuclear revenue through 2028. Key watch item: Progress on zero-outlay future-dated contracts like Palantir's $86.3M DHS ICE BPA (starts 2026) and GEO Group's $51M DHS detention services, amid high firm-fixed-price execution risks across 70%+ of awards.

18 total filings
· daily

Federal Professional Services Contracts — May 07, 2026

Two civilian professional services contracts totaling $211,571,573 in obligations were analyzed, with 0/2 defense-related, highlighting engineering and technical support (PSC R425) for federal agencies. Booz Allen Hamilton secured $112,687,934 from GSA for U.S. Army SETA services at Aberdeen Proving Ground, while Lynker Corporation won $98,883,639 from Department of Commerce/NOAA for National Centers for Environmental Prediction support. The highest-conviction bullish signal is Lynker's award (materiality 8/10, $62,376,621 outlayed), providing multi-year revenue stability through 2027. Dominant theme is civilian agency demand for specialized engineering services via full and open competition. Key risk is Booz Allen's negligible outlays (-$852 to date) despite high obligation, signaling potential execution delays.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — May 07, 2026

This digest covers $390,576,263 in total obligations across 6 Federal IT & Cybersecurity contracts, all civilian agency awards with 0 defense-related, spanning HHS/CMS, HUD, State, DOE, and VA. Dominant theme is steady civilian IT infrastructure and application support spending, led by HHS/CMS at ~$133M combined for VENTERA LLC ($83.7M) and Flexion Inc ($49.1M). Highest-conviction bullish signal is VENTERA LLC's $83.7M CMS QualityNet order with $58.8M already outlayed, signaling strong execution in healthcare IT. Key risk is high pricing risk on firm-fixed price structures across multiple awards like Microtechnologies LLC's $76.5M HUD contract; watch outlay progress and option exercises amid medium-term performance periods to 2027.

6 total filings
· daily

All HHS Contracts — May 07, 2026

HHS awarded $132,873,805 in total obligations across two CMS IT delivery orders to private contractors VENTERA LLC ($83.7M) and FLEXION INC ($49.1M), with zero defense-related activity in this civilian-focused stream. Dominant theme is CMS investment in healthcare IT infrastructure (QualityNet) and Medicare claims adjudication (MCADS), both under small business set-asides with significant outlays already ($58.8M for VENTERA, $31.9M for FLEXION). Highest-conviction signal is bullish on VENTERA LLC's firm fixed-price award, signaling strong execution on a high-materiality $83.7M obligation through 2027. Key risk is VENTERA's high pricing risk under firm fixed terms amid steady outlays. Watch option exercises toward ceilings ($101.7M for VENTERA, $51.1M for FLEXION) and performance to 2027 end dates.

2 total filings
· daily

All DOE Contracts — May 07, 2026

Two DOE civilian contracts totaling $135,168,251 in obligations highlight bullish signals in nuclear processing and IT services, with zero defense-related awards. BWX Technologies, Inc.'s subsidiary BWXT Nuclear Operations Group, Inc. leads with the highest-conviction bullish signal via a $79,811,931 non-competed firm fixed price delivery order from DOE NNSA for HALEU processing through 2028, representing specialized nuclear revenue. Accenture Federal Services LLC adds $55,356,320 in Time and Materials IT support from DOE Headquarters Procurement Services through 2027. Dominant themes center on DOE's NNSA nuclear priorities and headquarters IT modernization. Key risk: monitor progress on BWXT's remaining $23.8M obligation beyond $55.9M outlayed and option exercises to $116.7M ceiling, given high pricing risk.

2 total filings
· daily

Mega Contracts Monitor ($100M+) — May 07, 2026

Three mega civilian contracts totaling $332,043,294 obligations were awarded by GSA (two contracts) and VA (one), with 0/3 defense-related despite performance ties to Lackland AFB and Army PM TN at Aberdeen Proving Ground. Dominant agency theme is GSA Federal Acquisition Service funding professional services in biomedical R&D ($113M to ABSS SOLUTIONS INC) and Army SETA engineering ($113M to Booz Allen Hamilton INC), alongside VA medical disability exams ($106M to Veterans Evaluation Services, INC). Highest-conviction signal is bullish on Booz Allen Hamilton's $112,687,934 obligation with $32M options for multi-year Army support through potential 2025. Key risk is execution completion, with $106M already outlayed on ABSS (remaining ~$7M) and $94M on VES (completed 2021 contract). Average signal strength of 4.7/10 reflects neutral-to-bullish civilian services momentum amid low defense exposure.

3 total filings
· daily

High-Value Federal Grants ($5M+) — May 07, 2026

These 18 high-value federal contracts total $1,337,470,948 in obligations, with only 1 defense-related award (ABSS Solutions Inc.'s $113M biomedical R&D at Lackland AFB via GSA) amid 17 civilian-focused deals spanning GSA, VA, DHS, HHS/CMS, DOE, and NASA. Dominant themes center on civilian IT modernization (e.g., Palantir $86M DHS SaaS, Venterra $84M CMS infrastructure) and specialized services like DOE nuclear HALEU processing (BWXT $80M). Highest-conviction bullish signal is BWXT Nuclear Operations Group's $79.8M firm-fixed-price delivery order with $56M outlayed and options to $117M through 2028, signaling durable DOE NNSA revenue. Key watch item: Low/no outlays on future-dated awards like Palantir ($0 outlayed starting 2026) and GEO Group ($51M starting Dec 2025) expose them to execution delays amid CR risks.

18 total filings
· daily

DOE Energy Grants — May 07, 2026

DOE awarded $135,168,251 in obligations across two civilian contracts (0/2 defense-related) in nuclear processing and IT services, highlighting specialized capabilities in energy sector priorities. BWX Technologies, Inc.'s subsidiary BWXT Nuclear Operations Group, Inc. leads with the highest-conviction bullish signal via a $79.8M non-competed firm fixed-price delivery order for HALEU processing through 2028, representing durable multi-year revenue. Accenture Federal Services LLC adds $55.4M in IT support under full and open competition, with significant $49.1M already outlayed. Dominant theme is DOE NNSA and headquarters spending on nuclear tech and business applications. Key watch item: progress on BWXT's remaining $23.8M obligation and potential exercise of $36.9M options amid high pricing risk.

2 total filings
· daily

General Federal Contracts — May 07, 2026

Across 18 contracts totaling $1,337,470,948 in obligations, only 1 (ABSS Solutions Inc.'s $113M GSA award at Lackland AFB) is defense-related, with the remaining 17 skewed toward civilian agencies including GSA, VA, DHS, DOE, and HHS emphasizing IT services, health R&D, and facilities support. Dominant themes include civilian IT modernization and healthcare data management, with bullish signals for Palantir Technologies ($86M DHS ICE SaaS), BWXT Nuclear Operations ($79M DOE HALEU processing), and Lynker Corporation ($98M NOAA environmental support) highlighting multi-year revenue visibility. Highest-conviction bullish signal is BWXT's non-competed $79.8M DOE award (7/10 strength, 8/10 materiality) for specialized nuclear work through 2028, aligning with DOE NNSA priorities. Key risk is pervasive high fixed-price execution risk across 12 contracts (e.g., VES $106M VA, GEO Group $51M DHS), amplified by $0 outlays on future-dated awards like Palantir and Olsson Industrial Electric ($68M DOI). Watch multi-year option exercises, particularly for Booz Allen Hamilton's $112M Army SETA (potential to $144M) and Venterra LLC's $83M CMS IT ($101M ceiling).

18 total filings
· daily

All NASA Contracts — May 07, 2026

NASA's two contracts totaling $111,990,661 in obligations, awarded to nonprofit entities THE CHARLES STARK DRAPER LABORATORY, INC. ($56,933,211) and UTAH STATE UNIVERSITY SPACE DYNAMICS LABORATORY ($55,057,450), represent 100% civilian space R&D spending with 0/2 defense-related awards during the May 07, 2026 period. The dominant agency theme is NASA's sustained investment in lunar payloads via CLPS (Draper Lab) and atmospheric research via AWE (Utah State), both under full and open competition with significant outlays already at $43.3M and $48.2M respectively. Overall signals remain neutral (avg 3.5/10 strength), reflecting steady nonprofit funding but limited equity upside. Highest-conviction signal is outlay momentum toward full obligations amid long-duration performance periods through 2026-2027. Key risk: high pricing risk on Draper's firm fixed price structure; watch option exercises to reach $84.3M and $57.3M ceilings.

2 total filings
· daily

Nasdaq 100 Stocks SEC Filings — May 07, 2026

Across 50 SEC filings from NASDAQ-100 constituents for Q1 2026 (filed May 7), results reveal mixed performance with 12/22 earnings reports showing revenue declines averaging -4.2% YoY (e.g., Optimum -4%, Maximus -4%, MSG +2% outlier), offset by margin expansions in 8/22 cases (avg +90 bps, led by Warner Music +250 bps to 22.9%). Biotech and pharma firms (Evommune, ImmunityBio, Acadia, Gilead) highlight pipeline catalysts amid wider losses, while media/entertainment (Warner +17% revenue, MSG +2%) outperforms on streaming/concerts. Capital allocation trends positive with dividend hikes (Murphy, Saga $0.25, Chemung $0.34), buybacks (Maximus $400M refresh, Radian $50M, Gilead $419M), and 5 debt issuances/refinancings (Booking $750M, ADP $1B). Financials/banks show EPS surges (Camden +199% to $1.29, Chemung +53% to $1.91) despite asset flatness. Portfolio-level: 14/50 mixed sentiment, impairments drag telecom (Optimum $2.7B hit), but guidance raises (Maximus EBITDA +20bps to 14.2%, EPS +$0.20) and catalysts build alpha potential. Implications: Favor media/biotech turnarounds, monitor telecom leverage (Optimum 7.5x), rotate from laggards amid capex cuts (Optimum -13.6%).

24 high priority 26 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — May 07, 2026

Across the 50 pre-analyzed SEC filings from the USA S&P 500 Financials stream (though spanning diverse sectors including pharma, retail, energy, and tech), Q1 2026 results reveal resilient revenue growth averaging +25% YoY in 28/50 companies (e.g., Celsius +138%, Ormat +76%, Loar +36%), driven by acquisitions, volume ramps, and pricing, but offset by widespread margin compression (-200 to -400 bps in 15 cases like Celsius, GigaCloud) and cost inflation (SG&A up 9-25% in multiple filers). Profitability is mixed with net income rising in 18 cases (e.g., Targa +77%) but declining sharply in 20 (e.g., Bob's -81%, Kelly -op loss widening), amid active capital allocation via buybacks ($24M Celsius, $55M Targa, $17M Consensus) and dividends (Targa +25% YoY, BXSL 11.7% yield). M&A/divestitures dominate (Centessa-Lilly $38/share + CVR, Kontoor Lee divestiture, Spectrum Oaktree $127M), with 12 guidance raises (e.g., Targa EBITDA to $5.7-5.9B) signaling confidence, while 3 withdrawals (Leggett) flag uncertainty. Portfolio-level trends show improving free cash flow in 10 cases but cash burn/inventory builds in 12, implying selective opportunities in high-growth outperformers amid sector headwinds. Financials subset (BXSL, Aflac, WhiteHorse, FHLB Chicago) highlights stable dividends despite NII softness, underscoring defensive positioning.

12 high priority 38 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — May 07, 2026

Across 50 SEC filings dated May 7, 2026, primarily Q1 FY2026 results for diverse firms (despite Consumer Staples labeling, spanning consumer brands, biotech, energy, finance), revenue trends are mixed with standout growth in branded consumer plays (Celsius +138% YoY to $782.6M, Kontoor Brands +45% to $613M continuing ops, Tapestry +21% to $1.92B) contrasting declines (Aspen Aerogels -52% to $37.9M, Krispy Kreme -2.2% to $367M, Rockwell Medical -8% to $17.3M). Margin expansions prevalent in 7/15 detailed reporters (ARKO fuel +20.1% to 48c/gal, Krispy Kreme EBITDA +380bps to 9%, Callaway gross +250-260bps), but compressions hit growth firms (Claritev EBITDA margin -140bps to 60%, Celsius gross -400bps to 48.3%). Guidance largely raised or steady (Kontoor FY rev $3.41-3.46B up, Callaway sales $2.015-2.07B raised $35-70M, Tapestry ~$7.95B +14%; ARKO unchanged $245-265M EBITDA), signaling management conviction amid YoY improvements in net losses (ARKO -56% narrower, Climb Bio -34%). Capital allocation aggressive with buybacks (Kontoor $750M new auth, GigaCloud $12.3M Q1/$68M remain, Callaway 5.6M shares), dividends (ARKO $0.03/sh, Dorian LPG irregular $1.00/sh), and debt reduction (ARKO $206M via IPO). Biotech pipeline catalysts dense (Climb Bio Fast Track/FDA orphan, Monte Rosa Phase 2 H2 2026), while cash flows deteriorated in 6/12 (GigaCloud op cash $(21.7)M vs +$9.4M YoY, Claritev FCF $(92.5)M worse). Portfolio-level: 14/22 Q1 reporters avg +28% rev growth but -15% avg op cash YoY; mixed sentiment (18/22 mixed) implies selective opportunities in margin outperformers and guidance raisers.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — May 07, 2026

Across 50 SEC filings from S&P 500 Industrials and related sectors (May 7, 2026), Q1 2026 results dominate with mixed sentiment (24/37 detailed filings mixed), showing average revenue growth of ~25% YoY in biopharma/services (e.g., BridgeBio +67%, Codexis +102%, Pattern Group +43%) but persistent net losses widening in 12/20 cases amid rising opex/SG&A. Industrials-specific trends include sharp declines (Aspen Aerogels rev -52% YoY) offset by infrastructure plays like Target Hospitality's AI/data center board addition. Capital allocation leans shareholder-friendly with buybacks/repurchases in 8 filings (e.g., BridgeBio $500M, First Advantage $100M auth, Abacus $20M add'l), dividends steady (VAALCO $0.0625/share), and debt management (Ocugen repaid loan). Guidance mostly reaffirmed/raised (7/10 cases, e.g., Ligand royalty $225-250M up prior), signaling conviction despite cash burn; forward catalysts cluster Q2-Q3 (earnings, M&A closes, FDA nods). Portfolio-level: 15/50 show cash strengthens (avg +30% QoQ), but 10 flag risks like going concerns (Unity Forge), auditor resigns (Quest Water). Implications: Favor growth names with raised guidance/buybacks for near-term alpha, monitor industrials for capex/revenue recovery amid regulatory drags.

33 high priority 17 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — May 07, 2026

Across 29 filings in the USA S&P 500 Energy stream, energy firms like Cheniere entities and Targa Resources dominate with mixed Q1 2026 results: revenues grew 8-63% YoY in LNG operations but cost of sales surged 100-240% YoY, driving massive net losses (e.g., Cheniere $3.5B loss vs $353M income) due to $4.8B non-cash derivative hits, offset by strong Adjusted EBITDA (+13-25% YoY) and raised FY2026 guidance. Midstream peers Targa and Hess showed resilience with EBITDA/NI gains (Targa +19%/+77% YoY) and Permian volume records, while upstream Chevron (-37% NI) and APA (+28.5% NI despite -11.7% rev) reflect commodity price pressures. Capital returns accelerated with Targa's 25% div hike ($1.25/share), Cheniere distributions ($0.79/unit), and widespread buybacks ($542M Cheniere, $55M Targa). Non-energy noise (e.g., Papa Johns -7.7% rev, Xometry +36% rev) dilutes but highlights broader market cost inflation; 13Fs signal institutional interest in energy (e.g., Chesapeake's Conoco/Occidental/SLB positions). Portfolio trend: 6/9 energy cos with rev growth but margin compression averaging -500bps+ from costs, bullish EBITDA signals shareholder returns amid volatility. Key implication: Favor midstream over LNG/upstream for near-term stability, watch Q2 catalysts like Cheniere Train 6.

16 high priority 13 medium 29 total filings
· daily

US Material Events SEC 8-K Filings — May 07, 2026

Across 50 SEC filings from May 7, 2026, key themes include a wave of executive leadership changes (18 instances, mostly positive appointments like Target Hospitality's AI expert director and Shake Shack's experienced CFO), robust M&A activity (e.g., VSE's $2B accretive acquisition, Catalyst Pharma's $4.1B takeover at 28% premium, Cross Country's $437M take-private), and mixed Q1 2026 earnings with aggregate revenue growth in 12/20 reporting companies (avg +8% YoY) but volume declines in consumer segments (e.g., Post Holdings -10% ex-acquisitions, Joint Corp -4.9% system-wide). Capital raises dominated financings (ProPetro $600M notes, Avalo $405M equity, Ocugen $115M notes), bolstering liquidity amid some impairments (Ring Energy $162M non-cash). No widespread insider selling detected, but buybacks signaled conviction (Post $600M authorization, Life Time 2.2M shares). Healthcare/biotech showed outperformance with positive trial data and deals, while energy/consumer faced margin pressures (avg -100bps in 5 firms). Portfolio implication: Favor M&A targets for spreads, monitor consumer volume trends for shorts.

50 high priority 50 total filings